Longfellow Investment Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Longfellow Investment Management’s Portfolio OPTR Stock Details OPTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-757,000	Closed	-$9.53M	–	94
2013 Q3	$9.53M	Buy	+757,000	New	+$10M	1.51%	33

Longfellow Investment Management's OPTR Position: Q4 2013 in Review

Longfellow Investment Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 757,000 shares — an estimated $9.53M sold.

Longfellow Investment Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $9.53M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

Longfellow Investment Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
Longfellow Investment Management sold 757,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $9.53M.
Longfellow Investment Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
Longfellow Investment Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $9.53M in Q3 2013.
0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Longfellow Investment Management's 13F filing for Q4 2013, filed 3 Feb 2014.